Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice
The paper deals with the treatment policy, including erythropoiesis-stimulating drugs (ESD), in anemic patients with malignancies. The use of ESD remains the basic recommended treatment option for anemia in cancer patients treated with cytostatics if the causes of anemia, which are eliminable by oth...
Saved in:
Main Author: | N. V. Zhukov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of darbepoetin alpha in infants
by: A. V. Shchegolev, et al.
Published: (2019-06-01) -
Anemia of chronic diseases: the important aspects of pathogenesis and treatment
by: O. A. Rukavitsyn
Published: (2016-03-01) -
COST-MINIMIZATION ANALYSIS OF USING SHORT AND LONG-ACTING ERYTHROPOESIS-STIMULATING AGENTS FOR CORRECTION OF NEPHROGENIC ANEMIA AGAINST THE BACKGROUND OF SUBSTITUTION THERAPY
by: I. S. Krysanov, et al.
Published: (2021-10-01) -
PROSPECTS OF DIAGNOSTICS AND TREATMENT OF DIFFERENT ANEMIA KINDS IN CHILDREN
by: V. V. Botvinyeva, et al.
Published: (2012-10-01) -
Perspectives of treatment of anemias with cells of fetal liver, immobilized in macroporous alginate-gelatin carriers.
by: D. V. Gritsay, et al.
Published: (2014-06-01)